Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058696) titled 'BEATRICE (Best, Efficient and Affordable Training in Resilience In Constant Evolution) Platform Trial' on Nov. 1.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Open -no one is blinded
Control - Active
Primary Sponsor:
Institute - Kyoto University
Condition:
Condition - Adults with no to mild (subthreshold) depressive sypmtoms
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The overarching aim of this platform trial is to minimize the cumulative burden of depressive symptoms, measured as the sum of weekly to ...